Skip to Content
Is your RA under control? Take an assessment here >

Salsalate Pregnancy and Breastfeeding Warnings

Salsalate is also known as: Amigesic, Anaflex, Argesic-SA, Disalcid, Marthritic, Mono-Gesic, Salflex, Salsitab

Salsalate Pregnancy Warnings

Use should be avoided during the third trimester of pregnancy. Prior to third trimester: Use only if potential benefit justifies the potential risk to the fetus. US FDA pregnancy category: C Comments: Avoid use in late pregnancy as it may cause premature closure of the ductus arteriosus.

Animal studies have failed to reveal evidence of developmental abnormalities. Administration of nonsteroidal anti-inflammatory drugs (NSAIDs) during the third trimester of pregnancy may cause significant adverse effects, including premature closure of the fetal ductus. Animal studies with other prostaglandin synthesis inhibitors revealed evidence of increased dystocia, delayed parturition, and decreased pup survival during labor and delivery. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Salsalate Breastfeeding Warnings

Salicylic acid, the primary metabolite of this drug, has been shown to appear in human milk in concentrations approximating the maternal blood level. A nursing infant may ingest 30% to 80% as much salicylate per kilogram body weight as the mother is taking. The excretion of salicylate into breast milk increases disproportionately as the maternal dose increases. Reye's syndrome is associated with aspirin administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breast milk is unknown. An alternate drug is preferred over this drug during breastfeeding.

Caution is recommended. -According to some authorities: Use is not recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Salsalate (salsalate)." Amneal Pharmaceuticals, Glasgow, KY.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Salsalate (salsalate)." Amneal Pharmaceuticals, Glasgow, KY.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.